LEVETIRACETAM DEXCEL 750
देश: इसराइल
भाषा: अंग्रेज़ी
स्रोत: Ministry of Health
सूचना पत्रक
(PIL)
22-11-2021
सार्वजनिक आकलन रिपोर्ट
(PAR)
06-02-2020
अनुरोध भेजा।
सक्रिय संघटक:
LEVETIRACETAM
थमां उपलब्ध:
DEXCEL PHARMA TECHNOLOGIES LTD
ए.टी.सी कोड:
N03AX14
फार्मास्यूटिकल फॉर्म:
TABLETS
रचना:
LEVETIRACETAM 750 MG
प्रशासन का मार्ग:
PER OS
प्रिस्क्रिप्शन प्रकार:
Required
द्वारा बनाया गया:
DEXCEL LTD, ISRAEL
चिकित्सीय समूह:
LEVETIRACETAM
चिकित्सीय क्षेत्र:
LEVETIRACETAM
चिकित्सीय संकेत:
Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
प्राधिकरण की तारीख:
2018-03-31
